C.-B. Levaché

Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial

Antonio González-Martı́n, Christophe Desauw, Florian Heitz et al. · European Journal of Cancer · 2022 · 72 citations · Full text

Medicine, Oncology, Pharmacology +16

Adjuvant FOLFOX +/− cetuximab in fullRAS andBRAF wildtype stage III colon cancer patients

Ralyath Balogoun, Karine Le Malicot, Josep Tabernero et al. · Annals of Oncology · 2016 · 51 citations · Full text

Medicine, Oncology, Pharmacology +12

FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial

Jean‐Baptiste Bachet, Olivier Lucidarme, C.-B. Levaché et al. · European Journal of Cancer · 2018 · 27 citations

Medicine, Oncology, Chemotherapy +7

Transfusions and patient burden in chemotherapy-induced anaemia in France

Patricia K. Corey‐Lisle, Marie‐Pierre Desrosiers, Helen Collins et al. · Therapeutic Advances in Medical Oncology · 2014 · 19 citations

Medicine, Hematology, Oncology +16

Hemoglobin levels and quality of life in patients with symptomatic chemotherapy-induced anemia: the eAQUA study

Jean‐Loup Mouysset, Beata Freier, Joan van den Bosch et al. · Cancer Management and Research · 2016 · 16 citations · Full text

Medicine, Hematology, Oncology +17